Tamiflu Market Set to Surpass 2.7 Billion by 2034, Driven by Rising Influenza Cases and Key Developments
| TEVA Stock | USD 21.92 0.24 1.11% |
About 52% of Teva Pharma's investors are presently thinking to get in. The analysis of overall sentiment of trading Teva Pharma Industries stock suggests that some investors are interested at this time. The current market sentiment, together with Teva Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Teva Pharma Industries stock news signals to limit their universe of possible portfolio assets.
Teva |
The rising incidence of influenza, increased awareness of antiviral treatments, and key advancements in drug development and approvals are driving market expansion. Prominent players such as F. Hoffmann-La Roche, NATCO Pharma, and others are focusing on strategic partnerships and product innovations to strengthen their foothold in the global market.Wilmington, Delaware, Transparency Market Research Inc. , Dec. 11, 2024 -- The global Tamiflu market Merca
Read at finance.yahoo.com
 |
Teva Pharma Fundamental Analysis
We analyze Teva Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Teva Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Teva Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Teva Pharma is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Teva Pharma Industries Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Teva Pharma stock to make a market-neutral strategy. Peer analysis of Teva Pharma could also be used in its relative valuation, which is a method of valuing Teva Pharma by comparing valuation metrics with similar companies.
Peers
Teva Pharma Related Equities
| TLRY | Tilray | 1.69 | ||||
| CRON | Cronos | 1.02 | ||||
| LFCR | Lifecore Biomedical | 0.62 | ||||
| HLN | Haleon Plc | 0.54 | ||||
| ELAN | Elanco Animal | 0.08 | ||||
| VTRS | Viatris | 0.35 | ||||
| TAK | Takeda Pharmaceutical | 1.00 | ||||
| SNDL | SNDL | 1.11 | ||||
| ZTS | Zoetis | 2.05 | ||||
| BHC | Bausch Health | 2.75 | ||||
| ACB | Aurora Cannabis | 2.78 | ||||
| CGC | Canopy Growth | 3.11 | ||||
| SHPH | Shuttle Pharmaceuticals | 4.55 |
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |